Stock Events

Stock Events

Nektar Therapeutics (ITH.F) Q3 2024 Earnings

8AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.23

-0.21

-0.19

-0.17

Details

Expected EPS

-0.16946185

Actual EPS

-0.2290025

Surprise EPS

-0.06

Surprise Percent

+35.14%

Description

Nektar Therapeutics (ITH.F) has reported earnings of -0.2290025 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.